bicalutamide and ag-490

bicalutamide has been researched along with ag-490 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartsch, G; Comuzzi, B; Culig, Z; Hobisch, A; Jasarevic, Z; Lodde, M; Nemes, C; Offner, F; Pycha, A; Schmidt, S	1

Other Studies

1 other study(ies) available for bicalutamide and ag-490

Article	Year
The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer. The Journal of pathology, 2004, Volume: 204, Issue:2 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Cell Line, Tumor; CREB-Binding Protein; Down-Regulation; Enzyme Inhibitors; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Insulin-Like Growth Factor I; Interleukin-6; Male; Metribolone; Nitriles; Nuclear Proteins; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; RNA, Neoplasm; Tosyl Compounds; Trans-Activators; Tyrphostins; Up-Regulation	2004

Article

Year

The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer.

The Journal of pathology, 2004, Volume: 204, Issue:2

Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Cell Line, Tumor; CREB-Binding Protein; Down-Regulation; Enzyme Inhibitors; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Insulin-Like Growth Factor I; Interleukin-6; Male; Metribolone; Nitriles; Nuclear Proteins; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; RNA, Neoplasm; Tosyl Compounds; Trans-Activators; Tyrphostins; Up-Regulation

2004